[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Decongestant Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

June 2024 | 86 pages | ID: G3BE7D45D9A9EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Decongestant market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Decongestant industry chain, the market status of Hospitals (Tablets, Capsules), Research & Academic Laboratories (Tablets, Capsules), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Decongestant.

Regionally, the report analyzes the Decongestant markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Decongestant market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Decongestant market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Decongestant industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tablets, Capsules).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Decongestant market.

Regional Analysis: The report involves examining the Decongestant market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Decongestant market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Decongestant:

Company Analysis: Report covers individual Decongestant manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Decongestant This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Research & Academic Laboratories).

Technology Analysis: Report covers specific technologies relevant to Decongestant. It assesses the current state, advancements, and potential future developments in Decongestant areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Decongestant market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Decongestant market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Tablets
  • Capsules
  • Nasal Sprays
Market segment by Application
  • Hospitals
  • Research & Academic Laboratories
  • Clinic
  • Other
Major players covered
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Ranbaxy Laboratories Ltd.
  • Beximco Pharmaceuticals Ltd.
  • Novartis AG
  • Cipla Ltd.
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Decongestant product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Decongestant, with price, sales, revenue and global market share of Decongestant from 2019 to 2024.

Chapter 3, the Decongestant competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Decongestant breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Decongestant market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Decongestant.

Chapter 14 and 15, to describe Decongestant sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Decongestant
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Decongestant Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Tablets
  1.3.3 Capsules
  1.3.4 Nasal Sprays
1.4 Market Analysis by Application
  1.4.1 Overview: Global Decongestant Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospitals
  1.4.3 Research & Academic Laboratories
  1.4.4 Clinic
  1.4.5 Other
1.5 Global Decongestant Market Size & Forecast
  1.5.1 Global Decongestant Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Decongestant Sales Quantity (2019-2030)
  1.5.3 Global Decongestant Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Mylan N.V.
  2.1.1 Mylan N.V. Details
  2.1.2 Mylan N.V. Major Business
  2.1.3 Mylan N.V. Decongestant Product and Services
  2.1.4 Mylan N.V. Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Mylan N.V. Recent Developments/Updates
2.2 Teva Pharmaceutical Industries Ltd.
  2.2.1 Teva Pharmaceutical Industries Ltd. Details
  2.2.2 Teva Pharmaceutical Industries Ltd. Major Business
  2.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Product and Services
  2.2.4 Teva Pharmaceutical Industries Ltd. Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.3 Ranbaxy Laboratories Ltd.
  2.3.1 Ranbaxy Laboratories Ltd. Details
  2.3.2 Ranbaxy Laboratories Ltd. Major Business
  2.3.3 Ranbaxy Laboratories Ltd. Decongestant Product and Services
  2.3.4 Ranbaxy Laboratories Ltd. Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Ranbaxy Laboratories Ltd. Recent Developments/Updates
2.4 Beximco Pharmaceuticals Ltd.
  2.4.1 Beximco Pharmaceuticals Ltd. Details
  2.4.2 Beximco Pharmaceuticals Ltd. Major Business
  2.4.3 Beximco Pharmaceuticals Ltd. Decongestant Product and Services
  2.4.4 Beximco Pharmaceuticals Ltd. Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Beximco Pharmaceuticals Ltd. Recent Developments/Updates
2.5 Novartis AG
  2.5.1 Novartis AG Details
  2.5.2 Novartis AG Major Business
  2.5.3 Novartis AG Decongestant Product and Services
  2.5.4 Novartis AG Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Novartis AG Recent Developments/Updates
2.6 Cipla Ltd.
  2.6.1 Cipla Ltd. Details
  2.6.2 Cipla Ltd. Major Business
  2.6.3 Cipla Ltd. Decongestant Product and Services
  2.6.4 Cipla Ltd. Decongestant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Cipla Ltd. Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: DECONGESTANT BY MANUFACTURER

3.1 Global Decongestant Sales Quantity by Manufacturer (2019-2024)
3.2 Global Decongestant Revenue by Manufacturer (2019-2024)
3.3 Global Decongestant Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Decongestant by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Decongestant Manufacturer Market Share in 2023
  3.4.2 Top 6 Decongestant Manufacturer Market Share in 2023
3.5 Decongestant Market: Overall Company Footprint Analysis
  3.5.1 Decongestant Market: Region Footprint
  3.5.2 Decongestant Market: Company Product Type Footprint
  3.5.3 Decongestant Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Decongestant Market Size by Region
  4.1.1 Global Decongestant Sales Quantity by Region (2019-2030)
  4.1.2 Global Decongestant Consumption Value by Region (2019-2030)
  4.1.3 Global Decongestant Average Price by Region (2019-2030)
4.2 North America Decongestant Consumption Value (2019-2030)
4.3 Europe Decongestant Consumption Value (2019-2030)
4.4 Asia-Pacific Decongestant Consumption Value (2019-2030)
4.5 South America Decongestant Consumption Value (2019-2030)
4.6 Middle East and Africa Decongestant Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Decongestant Sales Quantity by Type (2019-2030)
5.2 Global Decongestant Consumption Value by Type (2019-2030)
5.3 Global Decongestant Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Decongestant Sales Quantity by Application (2019-2030)
6.2 Global Decongestant Consumption Value by Application (2019-2030)
6.3 Global Decongestant Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Decongestant Sales Quantity by Type (2019-2030)
7.2 North America Decongestant Sales Quantity by Application (2019-2030)
7.3 North America Decongestant Market Size by Country
  7.3.1 North America Decongestant Sales Quantity by Country (2019-2030)
  7.3.2 North America Decongestant Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Decongestant Sales Quantity by Type (2019-2030)
8.2 Europe Decongestant Sales Quantity by Application (2019-2030)
8.3 Europe Decongestant Market Size by Country
  8.3.1 Europe Decongestant Sales Quantity by Country (2019-2030)
  8.3.2 Europe Decongestant Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Decongestant Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Decongestant Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Decongestant Market Size by Region
  9.3.1 Asia-Pacific Decongestant Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Decongestant Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Decongestant Sales Quantity by Type (2019-2030)
10.2 South America Decongestant Sales Quantity by Application (2019-2030)
10.3 South America Decongestant Market Size by Country
  10.3.1 South America Decongestant Sales Quantity by Country (2019-2030)
  10.3.2 South America Decongestant Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Decongestant Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Decongestant Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Decongestant Market Size by Country
  11.3.1 Middle East & Africa Decongestant Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Decongestant Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Decongestant Market Drivers
12.2 Decongestant Market Restraints
12.3 Decongestant Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Decongestant and Key Manufacturers
13.2 Manufacturing Costs Percentage of Decongestant
13.3 Decongestant Production Process
13.4 Decongestant Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Decongestant Typical Distributors
14.3 Decongestant Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Decongestant Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Decongestant Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 4. Mylan N.V. Major Business
Table 5. Mylan N.V. Decongestant Product and Services
Table 6. Mylan N.V. Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Mylan N.V. Recent Developments/Updates
Table 8. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceutical Industries Ltd. Major Business
Table 10. Teva Pharmaceutical Industries Ltd. Decongestant Product and Services
Table 11. Teva Pharmaceutical Industries Ltd. Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 13. Ranbaxy Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Ranbaxy Laboratories Ltd. Major Business
Table 15. Ranbaxy Laboratories Ltd. Decongestant Product and Services
Table 16. Ranbaxy Laboratories Ltd. Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Ranbaxy Laboratories Ltd. Recent Developments/Updates
Table 18. Beximco Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Beximco Pharmaceuticals Ltd. Major Business
Table 20. Beximco Pharmaceuticals Ltd. Decongestant Product and Services
Table 21. Beximco Pharmaceuticals Ltd. Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Beximco Pharmaceuticals Ltd. Recent Developments/Updates
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Decongestant Product and Services
Table 26. Novartis AG Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Novartis AG Recent Developments/Updates
Table 28. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Ltd. Major Business
Table 30. Cipla Ltd. Decongestant Product and Services
Table 31. Cipla Ltd. Decongestant Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Cipla Ltd. Recent Developments/Updates
Table 33. Global Decongestant Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Decongestant Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Decongestant Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Decongestant, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Decongestant Production Site of Key Manufacturer
Table 38. Decongestant Market: Company Product Type Footprint
Table 39. Decongestant Market: Company Product Application Footprint
Table 40. Decongestant New Market Entrants and Barriers to Market Entry
Table 41. Decongestant Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Decongestant Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Decongestant Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Decongestant Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Decongestant Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Decongestant Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Decongestant Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Decongestant Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Decongestant Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Decongestant Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Decongestant Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Decongestant Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Decongestant Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Decongestant Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Decongestant Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Decongestant Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Decongestant Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Decongestant Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Decongestant Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Decongestant Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Decongestant Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Decongestant Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Decongestant Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Decongestant Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Decongestant Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Decongestant Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Decongestant Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Decongestant Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Decongestant Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Decongestant Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Decongestant Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Decongestant Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Decongestant Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Decongestant Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Decongestant Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Decongestant Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Decongestant Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Decongestant Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Decongestant Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Decongestant Raw Material
Table 101. Key Manufacturers of Decongestant Raw Materials
Table 102. Decongestant Typical Distributors
Table 103. Decongestant Typical Customers

LIST OF FIGURES

Figure 1. Decongestant Picture
Figure 2. Global Decongestant Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Decongestant Consumption Value Market Share by Type in 2023
Figure 4. Tablets Examples
Figure 5. Capsules Examples
Figure 6. Nasal Sprays Examples
Figure 7. Global Decongestant Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Decongestant Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Examples
Figure 10. Research & Academic Laboratories Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Decongestant Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Decongestant Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Decongestant Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Decongestant Average Price (2019-2030) & (USD/Unit)
Figure 17. Global Decongestant Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Decongestant Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Decongestant by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Decongestant Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Decongestant Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Decongestant Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Decongestant Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Decongestant Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Decongestant Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Decongestant Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Decongestant Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Decongestant Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Decongestant Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Decongestant Average Price by Type (2019-2030) & (USD/Unit)
Figure 32. Global Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Decongestant Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Decongestant Average Price by Application (2019-2030) & (USD/Unit)
Figure 35. North America Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Decongestant Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Decongestant Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Decongestant Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Decongestant Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Decongestant Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Decongestant Consumption Value Market Share by Region (2019-2030)
Figure 55. China Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Decongestant Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Decongestant Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Decongestant Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Decongestant Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Decongestant Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Decongestant Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Decongestant Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Decongestant Market Drivers
Figure 76. Decongestant Market Restraints
Figure 77. Decongestant Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Decongestant in 2023
Figure 80. Manufacturing Process Analysis of Decongestant
Figure 81. Decongestant Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications